Related references
Note: Only part of the references are listed.Dexrazoxane Exposure and Risk of Secondary Acute Myeloid Leukemia in Pediatric Oncology Patients
Alix E. Seif et al.
PEDIATRIC BLOOD & CANCER (2015)
Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: A longitudinal study
Tanya Renae Brown et al.
PEDIATRIC BLOOD & CANCER (2013)
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
Steven E. Lipshultz et al.
PEDIATRICS (2012)
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium
Lynda M. Vrooman et al.
EUROPEAN JOURNAL OF CANCER (2011)
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
Steven E. Lipshultz et al.
LANCET ONCOLOGY (2010)
Long-term results of the Spanish Protocol SO-95 for the treatment of non-metastatic high-grade osteosarcoma of the extremities in children
Arturo Munoz et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J
Yukihide Iwamoto et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2009)
Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival - A report from the Children's Oncology Group
Paul A. Meyers et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma
Alessandra Longhi et al.
ANTI-CANCER DRUGS (2007)
SFOPOS94:: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients
Marie-Cecile Le Deley et al.
EUROPEAN JOURNAL OF CANCER (2007)
Dexrazoxane-Associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease
Cameron K. Tebbi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Long-term cardiac follow-up in survivors of a malignant bone tumour
C. A. J. Brouwer et al.
ANNALS OF ONCOLOGY (2006)
Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy
G Bacci et al.
EUROPEAN JOURNAL OF CANCER (2005)
Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity:: A joint study by the Italian and Scandinavian Sarcoma Groups
S Ferrari et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric oncology group study POG-8651
AM Goorin et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: A Pediatric Oncology Group trial
AM Goorin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
